SecBot SecBot
Insider Cluster (2 insiders) ·Filed Mar 30, 2026

DYN

Dyne Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed7mo ago
Insider cluster: 2 insiders, $141K total
Actionable Insight • Neutral

Monitor for follow-up transactions, particularly from other C-suite executives, as isolated CFO selling paired with a small board buy is not strongly directional at this volume. No immediate catalyst is evident.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$17.09
T+0 close · Mar 29, 2026 · via day close
Latest settled
+20.60%
T+60 · $20.61
Vs SPY
+4.11%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 30 $17.09entry
  2. T+1 · 8mo ago +6.09%α +3.19% · $18.13
  3. T+5 · 7mo ago +6.26%α +1.96% · $18.16
  4. T+20 · 7mo ago +6.26%α −6.34% · $18.16
  5. T+60 · 5mo ago +20.60%α +4.11% · $20.61
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A mixed insider trading cluster at Dyne Therapeutics shows CFO Erick Lucera selling $107K in shares while Director Brian Posner bought $34K, all within a 7-day window. The net selling by a C-suite executive outweighs the board-level purchase, but total volume remains below 0.1% of market cap.

Key Financial Metrics

Direction
mixed
Total Value
$140.9K
Insiders
2

Key Facts

  • CFO Erick Lucera sold 5,727 shares for $106,751 in open-market transactions on April 1, 2026.
  • Director Brian Posner purchased 2,000 shares for $34,160 on March 30, 2026.
  • Total cluster value is $140,911, representing just 0.0045% of Dyne Therapeutics' $3.1B market cap.
  • Net direction is mixed, with $107K in sales and $34K in purchases by corporate insiders.

Financial Impact

$141K total insider activity, net $73K in selling over 7 days

insider sentimentshareholder confidence

Risk Factors

  • CFO selling could signal caution ahead of a key clinical readout or financing need.
  • Low trade volume limits interpretive power; activity may be routine portfolio management.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-DYN-1775247052856

Track record

54 reports on DYN

Performance horizon

12 of 16 bullish or bearish reports moved the stock their way by T+20. Best: +46.36% at T+60 after the May 20, 2026 report. 15 of 16 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $16.77 Now $16.70 −0.39% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  3. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  4. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $17.36 Now $16.70 −3.80% settles Dec 4
  6. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $17.04 Now $16.70 −2.00% settles Nov 27
  7. Oct 22, 202625d ago Press Release Neutral 2/10 Entry $15.62 Now $16.70 +6.91% settles Nov 20
  8. Oct 12, 20265w ago Institutional Cluster Mixed 4/10 Entry $15.96 to $18.62 Now $16.70 +4.64% ▲ +16.67% +19.93% vs SPY
  9. Sep 29, 20266w ago Press Release Bullish 7/10 Entry $16.11 to $16.94 Now $16.70 +3.66% ▲ +5.15% +4.23% vs SPY
  10. Sep 8, 20269w ago Insider Cluster Neutral 3/10 Entry $19.19 to $15.97 Now $16.70 −12.98% ▼ −16.78% −18.72% vs SPY
Showing 10 of 54

US Market Status

Market Closed · Opens Wed (11h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 3, 2026